newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced it has been selected for addition to the